Entheon Biomedical Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 25, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019
Market Capitalization	1	1	2	32	31	-
Market Cap Growth	-27.18%	-66.67%	-94.44%	3.86%	-	-
Enterprise Value	1	0	2	28	29	-
Last Close Price	0.10	0.10	0.30	5.40	7.60	-
PE Ratio	-	-1.97	-0.21	-3.30	-4.76	-
PS Ratio	-	2.36	9.35	-	-	-
PB Ratio	3.02	1.87	2.88	3.52	8.20	-
P/FCF Ratio	-4.29	-1.64	-0.91	-5.98	-10.78	-
P/OCF Ratio	-4.29	-1.64	-0.91	-5.98	-10.82	-
EV/Sales Ratio	-	0.84	8.04	-	-	-
EV/EBITDA Ratio	-	-	-0.42	-3.48	-17.58	-
EV/EBIT Ratio	-3.55	-0.67	-0.42	-3.47	-17.55	-
EV/FCF Ratio	-3.58	-0.58	-0.78	-5.35	-10.12	-
Debt / Equity Ratio	-	-	-	-	-	0.07
Debt / FCF Ratio	-	-	-	-	-	-0.01
Asset Turnover	-	0.43	0.04	-	-	-
Quick Ratio	7.30	4.11	4.67	2.24	4.00	1.22
Current Ratio	7.95	4.64	4.81	3.46	6.05	1.45
Return on Equity (ROE)	-86.71%	-64.49%	-42.66%	-125.03%	-231.39%	-
Return on Assets (ROA)	-48.64%	-33.54%	-41.88%	-71.06%	-44.49%	-
Return on Capital (ROIC)	-56.79%	-42.19%	-46.57%	-80.25%	-54.11%	-
Earnings Yield	-53.93%	-50.77%	-480.67%	-27.87%	-14.27%	-
FCF Yield	-23.33%	-60.91%	-110.26%	-16.72%	-9.27%	-
Buyback Yield / Dilution	-6.00%	-	-8.85%	-97.83%	-543.78%	-
Total Shareholder Return	-6.00%	-	-8.85%	-97.83%	-543.78%	-

Source: S&P Capital IQ. Standard template. Financial Sources.